Immatics N.V. IMTX
Annual
Quarterly
No annual revenue total was found in Immatics N.V.'s SEC filings.
Immatics N.V. (IMTX) files with the SEC under industry code 2836, Biological Products, (No Diagnostic Substances).
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
134.07M
+10.3% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Tubingen, Germany
- SEC filer status
- Accelerated filer
- SEC CIK
- 1809196
- Former names
- Immatics B.V. (until Jul 8, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 24, 2026 |
| 6-K | Current report (foreign issuer) | Oct 23, 2026 | Oct 23, 2026 |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 26, 2026 |
| 6-K | Current report (foreign issuer) | Aug 18, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 18, 2026 | Jun 18, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
All 243 Immatics N.V. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.